Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20030224023 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 10/347,982
Fecha de publicación4 Dic 2003
Fecha de presentación21 Ene 2003
Fecha de prioridad29 May 2002
También publicado comoCA2485335A1, CN1278667C, CN1655757A, EP1507512A1, WO2003099252A1
Número de publicación10347982, 347982, US 2003/0224023 A1, US 2003/224023 A1, US 20030224023 A1, US 20030224023A1, US 2003224023 A1, US 2003224023A1, US-A1-20030224023, US-A1-2003224023, US2003/0224023A1, US2003/224023A1, US20030224023 A1, US20030224023A1, US2003224023 A1, US2003224023A1
InventoresJoseph Faryniarz, Anthony Johnson, Michael Cheney, Timothy Anto
Cesionario originalUnilever Home & Personal Care Usa, Division Of Conopco, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Cosmetic compositions with hydroxy amine salts of malonic acid
US 20030224023 A1
Resumen
A new cosmetic ingredient, composition and method for cosmetically treating skin is provided which utilizes mono-hydroxy substituted amine salts of malonic acid. Particularly preferred are dimethylaminoethanol (DMAE) salts of malonic acid.
Imágenes(8)
Previous page
Next page
Reclamaciones(9)
What is claimed is:
1. A cosmetic composition comprising:
(i) from about 0.0001 to about 30% by weight of a mono-hydroxy substituted amine salt of malonic acid; and mixtures thereof:
(ii) from about 1 to about 99.9% by weight of a cosmetically acceptable carrier.
2. The composition according to claim 1 wherein the salt is formed from an amine which is dimethylaminoethanol.
3. The composition according to claim 1 wherein the malonic acid is present as a half neutralized and a fully neutralized acid in a molar ratio ranging from about 1000:1 to about 1:1000, respectively.
4. The composition according to claim 3 wherein the molar ratio is about 2:1 to about 1:200.
5. The composition according to claim 1 wherein the pH ranges from about 4 to less than about 7.
6. A cosmetic composition comprising:
(i) from about 0.0001 to about 30% by weight of a mono-hydroxy substituted amine salt of malonic acid of general formula I, II and mixtures thereof:
[HO2CCH2CO2][X]+  I +[X]2[O2CCH2CO2]−2   II
wherein X is a protonated salt of a mono-hydroxy substituted amine, the amine in non-protonated form having general formula III:
wherein R1and R2 are branched or unbranched C1-C30 radicals selected from the group consisting of alkyl, cycloalkyl, alkenyl, aryl, alkylaryl, alkoxyalkyl and combinations thereof;
R3 is a branched or unbranched C1-C30 radical selected from the group consisting of alkylene, cycloalkylene, arylene and combinations thereof; and
R1 with R2 can optionally form a ring and independently R1 with R3 can form a ring; and
(ii) from 1 to 99.9% by weight of a cosmetically acceptable carrier.
7. The composition according to claim 6 wherein the amine is dimethylaminoethanol.
8. A dimethylaminoethanol salt of malonic acid.
9. A method for controlling signs of aging including those selected from the group consisting of fine lines, wrinkles, sagging skin, poor tone and age spots, comprising
providing a cosmetic composition comprising:
(i) from about 0.0001 to about 30% by weight of a mono-hydroxy substituted amine salt of malonic acid;
(ii) from about 1 to about 99.9% by weight of a cosmetically acceptable carrier;
applying the cosmetic composition to the skin.
Descripción
    BACKGROUND OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    The invention concerns cosmetic compositions containing malonic acid salts which combat the signs of skin aging.
  • [0003]
    2. The Related Art
  • [0004]
    A soft, supple and flexible skin has a marked cosmetic appeal and is an attribute of normal functioning epidermis. As human skin ages with advancing years, the epidermis can become folded, ridged or furrowed to form wrinkles. These signal loss of youthful appearance and herald the transition to old age. Exposure to excessive doses of sunlight accelerates the transition process. Also, the outer layer of the epidermis known as the stratum corneum can become dry and flaky following exposure to cold weather or excessive contact with detergents or solvents. Loss of skin moisture thereby results and the skin begins to lose the soft, supple and flexible characteristics.
  • [0005]
    Emollients such as fats, phospholipids and sterols have in the past been used to soften wrinkled or dry skin. These emollients are only partially effective as a remedy for skin in poor condition.
  • [0006]
    The use of hydroxy carboxylic acids for enhancing the quality of human skin has been known for some time. There is no doubt that alpha-hydroxy carboxylic acids are effective much beyond the common emollients.
  • [0007]
    U.S. Pat. No. 4,424,234 (Alderson et al.) discloses skin treatment compositions incorporating alpha-hydroxycaproic acid and alpha-hydroxycaprylic acid or mixtures thereof in compositions that have a pH value of less than 7, usually from 2 to 4. Yu and Van Scott have patented widely in this area. For instance, U.S. Pat. No. 4,105,782 reports amines or ammonium salts of alpha-hydroxy carboxylic acids in the treatment of acne or dandruff. In U.S. Pat. No. 4,105,783 and U.S. Pat. No. 4,197,316, these compounds are suggested for the treatment of dry skin. U.S. Pat. No. 4,234,599 discloses the use of alpha-hydroxy carboxylic acids, their esters or amine salts in the treatment of keratoses. More recently, U.S. Pat. No. 5,091,171 focused attention on these compounds as being effective against age spots, wrinkles and aging related skin changes.
  • [0008]
    While hydroxy carboxylic acids hold much therapeutic promise, the materials have been found to irritate human skin on repeated topical applications. The irritation may range from a sensation of tingling, itching and burning to clinical signs of redness and peeling. Causes for such irritation have been linked to the lowering of pH in the stratum corneum of human skin. Low pH has been suggested as provoking disturbances in intercorneocyte bondings resulting in adverse skin reactions, specialty in some individuals with sensitive skin.
  • [0009]
    Organic acids other than alpha-hydroxy functionatized have been disclosed in the cosmetic literature. For instance, U.S. Pat. No. 5,641,495 (Jokura et at.) discloses in combination a ceramide or pseudoceramide, a dicarboxylic acid and a salt of a dicarboxylic acid. The Examples illustrate sodium and potassium salts of succinic acid. Lower molecular weight dicarboxytic acids such as malonic may also be utilized. Although excellent moisturization and little accompanying irritation occurs, there is no suggestion that this system combats signs of aging such as advent of fine lines and wrinkles. Improvements in the general anti-aging technology of skin remains as an unfulfilled need of the consumer.
  • [0010]
    Accordingly, it is an advantage of the present invention to provide new cosmetic ingredients in compositions which are effective at controlling and even eliminating the signs of aging, particularly fine lines, wrinkles, sagging skin, poor tone and age spots.
  • SUMMARY OF THE INVENTION
  • [0011]
    A cosmetic composition is provided which includes:
  • [0012]
    (i) from about 0.0001 to about 30% by weight of a mono-hydroxy substituted amine salt of matonic acid; and
  • [0013]
    (ii) from about 1 to about 99.9% by weight of a cosmetically acceptable carrier.
  • [0014]
    Furthermore, the present invention provides a set of new cosmetically active ingredients. In particular, the dimethylaminoethanol salts of malonic acid have proven very effective.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0015]
    We have now found a class of salts which are at least as effective as alpha-hydroxy carboxylic acids. These salts are based on a select dicarboxylic acid neutralized with a select class of amines to form the active salt ingredient. These salts may either be partially or fully neutralized carboxylic salts as represented by general formulas (I) and (II):
  • [HO2CCH2CO2][X]+  I
  • +[X] 2[O2CCH2CO2]−2   II
  • [0016]
    wherein X is a protonated salt of a mono-hydroxy substituted amine, the amine in non-protonated form having general formula III:
  • [0017]
    wherein R1 and R2 are branched or unbranched C1-C30 radicals selected from the group consisting of alkyl, cycloalkyl, alkenyl, aryl, alkylaryl, alkoxyalkyl and combinations thereof;
  • [0018]
    R3 is a branched or unbranched C1-C30 radical selected from the group consisting of alkylene, cycloalkylene, arylene and combinations thereof; and
  • [0019]
    R1 with R2 can optionally form a ring and independently R1 with R3 can form a ring.
  • [0020]
    Illustrative mono-hydroxy amines include dimethylaminoethanol, diethyl aminoethanol, diisopropylaminoethanol, ethylmethylamino-ethanolamine, methylbutylaminoethanolamine, dimethylamino-methanol, diethylaminomethanol, methylethylaminomethanol, dimethylaminopropyanol, diethylaminopropanol, dipropylamino-propanol, ethylpropylaminopropanol, diphenylaminoethanol, methyl-phenylaminoethanol, para-toluoylmethylaminoethanol, dimethylaminophenylethanol, piperidinylethanol, 2-methylpyridinyl-ethanol, 2-pyrrolidonylethanol and pyrrolylethanol. Most preferred is dimethylaminoethanol (DMAE).
  • [0021]
    Amounts of the amine neutralized malonate salt may range from about 0.0001 to about 30%, preferably from about 0.1 to about 15%, more preferably from about 0.5 to about 10%, optimally from about 1 to about 8% by weight of the cosmetic composition.
  • [0022]
    The present invention can utilize as the active ingredient salt I, salt II or mixtures of these salts. When mixtures are present the molar ratio of mono-salt I to di-salt II may range from about 1000:1 to about 1:1000, preferably from about 10:1 to about 1:500, more preferably from about 2:1 to about 1:200, optimally from about 1:1 to about 1:20.
  • [0023]
    Compositions of this invention may have a pH ranging from about 2.5 to about 8.5, preferably from about 3 to about 8, optimally from about 4 to less than about 7.
  • [0024]
    Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the carrier may range from 1 to 99.9%, preferably from about 70 to about 95%, optimally from about 80 to about 90%. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, humectants, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or OW variety. Water when present may be in amounts ranging from about 5 to about 95%, preferably from about 20 to about 70%, optimally from about 35 to about 60% by weight.
  • [0025]
    Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1 to about 95%, preferably between about 1 and about 50% by weight.
  • [0026]
    Silicone oils may be divided into the volatile and nonvolatile variety.
  • [0027]
    The term “volatile” as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
  • [0028]
    Nonvolatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5×10−6 to 0.1 m2/s at 25° C. Among the preferred nonvolatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1×10−5 to about 4×10−4 m2/s at 25° C.
  • [0029]
    Another class of nonvolatile silicones are emulsifying and non-emulsifying silicone elastomers. Representative of this category is Dimethicone/Vinyl Dimethicone Crosspolymer available as Dow Corning 9040, General Electric SFE 839, and Shin-Etsu KSG-18. Silicone waxes such as Silwax WS-L (Dimethicone Copolyol Laurate) may also be useful.
  • [0030]
    Among the ester emollients are:
  • [0031]
    (1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
  • [0032]
    (2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
  • [0033]
    (3) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols.
  • [0034]
    (4) Wax esters such as beeswax, spermaceti wax and tribehenin wax.
  • [0035]
    (5) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
  • [0036]
    (6) Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
  • [0037]
    Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
  • [0038]
    Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable carriers. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids.
  • [0039]
    Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative of this category are stearyl alcohol, lauryl alcohol, myristyl alcohol and cetyl alcohol.
  • [0040]
    Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition.
  • [0041]
    Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 982®), hydrophobically-modified acrylates (e.g. Carbopol 1382®), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenam, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonites and hectorites, fumed silicas, and silicates such as magnesium aluminum silicate (Veegum®). Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.
  • [0042]
    Cosmetic compositions of the present invention may be in any form. These forms may include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosol sprays and pad-applied formulations.
  • [0043]
    Surfactants may also be present in cosmetic compositions of the present invention. Total concentration of the surfactant when present may range from about 0.1 to about 40%, preferably from about 1 to about 20%, optimally from about 1 to about 5% by weight of the composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide;
  • [0044]
    mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di-C8-C20 fatty acids; and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic surfactants.
  • [0045]
    Preferred anionic surfactants include soap, alkyl ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isethionate, C8-C20 alkyl ether phosphates, C8-C20 sarcosinates and combinations thereof.
  • [0046]
    Sunscreen actives may also be included in compositions of the present invention. Particularly preferred are such materials as ethylhexyl p-methoxycinnamate, available as Parsol MCX®, Avobenzene, available as Parsol 1789® and benzophenone-3, also known as Oxybenzone. Inorganic sunscreen actives may be employed such as microfine titanium dioxide, zinc oxide, polyethylene and various other polymers. Amounts of the sunscreen agents when present may generally range from 0.1 to 30%, preferably from 2 to 20%, optimally from 4 to 10% by weight.
  • [0047]
    Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
  • [0048]
    Compositions of the present invention may also contain vitamins. Illustrative water-soluble vitamins are Niacinamide, Vitamin B2, Vitamin B6, Vitamin C and Biotin. Among the useful water-insoluble vitamins are Vitamin A (retinol), Vitamin A Palmitate, Ascorbyl Tetraisopalmitate, Vitamin E (tocopherol), Vitamin E Acetate and DL-panthenol. Total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight.
  • [0049]
    Another adjunct ingredient can be that of an enzyme. Particularly preferred is superoxide dismutase, commercially available as Biocell SOD from the Brooks Company, USA.
  • [0050]
    Skin lightening agents may be included in the compositions of the invention. Illustrative substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, resorcinol and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from about 0.1 to about 10%, preferably from about 0.5 to about 2% by weight of the compositions.
  • [0051]
    Desquamation agents are further optional components. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. Among the former are salts of glycolic acid, lactic acid and malic acid. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.1 to about 15% by weight of the composition.
  • [0052]
    A variety of herbal extracts may optionally be included in compositions of this invention. Illustrative are green tea, chamomile, licorice and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.
  • [0053]
    Anti-microbiat agents may also be included in the compositions of this invention. Illustrative are trichlosan, trichlocarban, Octopyrox® and zinc pyrithione. Amounts may range from about 0.01 to about 5%, preferably from about 0.1 to about 0.5% by weight of the composition.
  • [0054]
    Colorants, fragrances, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from about 0.05 to about 5%, preferably between 0.1 and 3% by weight.
  • [0055]
    The term “comprising” is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words “including” or “having” are used, these terms are meant to be equivalent to “comprising” as defined above.
  • [0056]
    Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word “about”.
  • [0057]
    The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.
  • EXAMPLE 1
  • [0058]
    A clinical study was conducted to compare dimethylaminoethanol (DMAE) malonate to ammonium glycolate as active cosmetic ingredients. The base formula for the comparative experiments is outlined under Table I.
    TABLE I
    INGREDIENT WEIGHT %
    PHASE A
    Water Balance
    Disodium EDTA 0.05
    Methyl Paraben 0.15
    Magnesium Aluminum Silicate 0.60
    Triethanolamine 1.20
    PHASE B
    Xanthan Gum 0.20
    Natrosol ® 250HHR (ethyl cellulose) 0.50
    Butylene Glycol 3.00
    Glycerin 2.00
    PHASE C
    Sodium Stearoyl Lactylate 0.10
    Glycerol Monostearate 1.50
    Stearyl Alcohol 1.50
    Isostearyl Palmitate 3.00
    Silicone Fluid 1.00
    Cholesterol 0.25
    Sorbitan Stearate 1.00
    Butylated Hydroxy Toluene 0.05
    Vitamin E Acetate 0.01
    PEG-100 Stearate 2.00
    Stearic Acid 3.00
    Propyl Paraben 0.10
    Parsol MCX ® 2.00
    Caprylic/Capric Triglyceride 0.50
    Hydroxycaprylic Acid 0.01
    C12-15 Alkyl Octanoate 3.00
    PHASE D
    Active
    PHASE E
    Vitamin A Palmitate 0.10
    Bisabolol 0.01
    Vitamin A Acetate 0.01
    Fragrance 0.03
    Retinol 50C 0.02
  • [0059]
    The total formulations with ammonium glycolate and DMAE malonate active are identified in the Tables below as “PADC” and “DMAE”, respectively. The PADC product is a state of the art alpha hydroxy acid formula which is currently in the market. This formula contains 8% Glycolic acid or 0.1053 equivalents, neutralized with 2.4% ammonia hydroxide which is 0.0395 equivalents, resulting in a final formula pH of 3.8. The DMAE formula contains 2.58% malonic acid or 0.0496 equivalents, neutralized with 3.20% DMAE which is 0.0358 equivalents, resulting in a final formula pH of 5.5. This resulted in Malonic acid being 72.2% neutralized by the amine. The clinical involved (49) panelists over a six week period. Panelists were required to apply each product to one half of their face. After application, the panelists were required to answer a series of questions regarding relative effectiveness of the products.
    TABLE II
    Week 1 Week 3 Week 6
    Products: (n = 49) (n = 49) (n = 47)
    PADC & DMAE DMAE no DMAE no DMAE
    Malonate pH 5.5 PADC pH 5.5 pref PADC pH 5.5 pref PADC pH 5.5 No pref
    Absorbed more easily 45 29 27 51 30 19 43 30 28
    Felt less greasy 33 37 31 47 26 28 45 32 23
    Felt lighter 40 44 17 42 39 19 51 36 13
    Left skin feeling softer 16 29 55 23 19 58 15 28 57
    Was milder 18 37 45 30 26 44 19 40 40
    Left skin feeling smoother 16 31 53 21 23 56 19 28 53
    Left skin looking smoother 20 27 53 21 16 63 19 26 55
    Moisturized better 16 31 53 21 35 44 23 28 49
    Helped to look firmer/tighter 18 18 63 28 9 63 28 11 62
    Helped to feel healthier 16 22 61 23 16 61 19 21 60
    Helped to feel firmer/tighter 18 25 57 24 7 69 25 13 62
    Improved skin tone better 16 20 63 28 7 65 30 13 57
    Made skin look better 12 29 59 23 14 63 28 23 49
    Improved condition better 10 25 65 19 7 74 28 23 49
    Helped to look younger 12 16 71 16 14 70 28 19 53
    Left skin more radiant 10 20 69 16 12 72 28 17 55
    Was less irritating 22 39 39 16 35 49 9 38 53
    Was evening out tone/texture 12 16 71 19 7 74 25 15 60
    Firmed skin better 10 25 65 19 12 70 23 19 57
    Overall preference
    Products: Week 1 Week 3 Week 6
    PADC & DMAE DMAE no DMAE no DMAE No
    Malonate pH 5.5 PADC pH 5.5 pref PADC pH 5.5 pref PADC pH 5.5 pref
    Overall Preference 33 45 22 44 30 26 45 32 23
  • [0060]
    The effect of pH was evaluated with another set of panelists numbering (58) persons utilizing a formulation at pH 6.5. In this set, 2.05% or 0.0394 equivalents of Malonic acid was neutralized with 3.17% or 0.0356 equivalents of DMAE resulting in a formula with a pH of 6.5. In this formula the malonic acid was 90.35% neutralized with the DMAE. In both DMAE formulas the lower pKa malonic acid group was totally neutralized, depending on the amount of malonic acid present in each formula. The second higher pKa acid group was partially neutralized with the remaining DMAE equivalents to bring the pH up to the desired value. Results of that evaluation are listed under Table III.
    TABLE III
    Products: Week 1 (n = 58) Week 3 (n = 58) Week 6 (n = 57)
    PADC & DMAE DMAE No DMAE No DMAE No
    Malonate pH 6.5 PADC pH 6.5 pref PADC pH 6.5 pref PADC pH 6.5 pref
    Absorbed more easily 52 31 17 54 23 23 53 30 17
    Felt less greasy 47 36 17 54 25 21 49 35 16
    Felt lighter 66 22 12 64 25 12 70 18 12
    Left skin feeling softer 29 35 36 29 33 38 25 26 49
    Was milder 26 48 26 23 42 35 21 46 33
    Left skin feeling smoother 26 28 47 29 25 46 26 28 46
    Left skin looking smoother 21 24 55 19 25 56 17 25 58
    Moisturized better 26 36 38 29 35 37 25 44 32
    Helped to look firmer/tighter 21 19 60 17 23 60 23 28 49
    Helped to feel healthier 22 26 52 15 23 62 23 25 53
    Helped to feel firmer/tighter 28 22 50 19 27 54 30 30 40
    Improved skin tone better 17 24 59 14 19 67 14 19 67
    Made skin look better 22 21 57 25 19 56 17 25 58
    Improved condition better 19 22 59 17 21 62 18 28 54
    Helped to look younger 16 17 67 15 19 65 14 28 58
    Left skin more radiant 22 22 55 12 15 73 16 25 60
    Was less irritating 10 45 45 10 42 48 12 39 49
    Was evening out tone/texture 16 22 62 14 23 63 18 19 63
    Firmed skin better 16 22 62 21 29 50 23 28 49
    Overall Preference
    Products: Week 1 Week 3 Week 6
    PADC & DMAE DMAE no DMAE No DMAE No
    Malonate pH 6.5 PADC pH 6.5 pref PADC pH 6.5 pref PADC pH 6.5 pref
    Overall Preference 41 38 21 50 37 13 35 42 23
  • [0061]
    Based on the results of the clinical evaluations, it is evident that DMAE malonate is as effective as ammonium glycolate, the well-known, but irritation inducing active, in respect of improving the general condition of skin. Additionally, the clinical found that DMAE malonate was considerably less irritating than the ammonium glycolate composition. Yet, efficacy was not compromised at the higher pH, with the new material This is unexpected, as the effectiveness of typical alpha hydroxy acids or salts, are known to be less effective at pH greater than 4.
  • EXAMPLE 2
  • [0062]
    A water-in-oil topical Liquid make-up foundation utilizing the malonate salts of the present invention is described in Table IV below.
    TABLE IV
    INGREDIENT WEIGHT %
    PHASE A
    Cyclomethicone 9.25
    Cetyl Octanoate 2.00
    Dimethicone Copolyol 20.00
    PHASE B
    Talc 3.38
    Pigment (Iron Oxides) 10.51
    Spheron L-1500 (Silica) 0.50
    PHASE C
    Synthetic Wax Durachem 0602 0.10
    Arachidyl Behenate 0.30
    PHASE D
    Cyclomethicone 1.00
    Trihydroxystearin 0.30
    PHASE E
    Laureth-7 0.50
    Propyl Paraben 0.25
    PHASE F
    Fragrance 0.05
    PHASE G
    Water balance
    DMAE Malonate 3.00
    Methyl Paraben 0.12
    Propylene Glycol 8.00
    Niacinamide 4.00
    Glycerin 3.00
    Sodium Chloride 2.00
    Sodium Dehydroacetate 0.30
  • EXAMPLE 3
  • [0063]
    Illustrated herein is a skin cream incorporating the malonate salts of the present invention.
    TABLE V
    INGREDIENT WEIGHT %
    Glycerin 6.93
    Niacinamide 5.00
    DMAE Malonate 5.00
    Permethyl 101A1 3.00
    Sepigel 3052 2.50
    Q2-14033 2.00
    Isopropyl Isostearate 1.33
    Arlatone 21214 1.00
    Cetyl Alcohol CO-1695 0.72
    SEFA Cottonate5 0.67
    Tocopherol Acetate 0.50
    Panthenol 0.50
    Stearyl Alcohol 0.48
    Titanium Dioxide 0.40
    Disodium EDTA 0.10
    Glydant Plus6 0.10
    PEG-100 Stearate 0.10
    Stearic Acid 0.10
    Purified Water Balance
  • EXAMPLE 4
  • [0064]
    Illustrative of a powdered cosmetic composition according to the present invention is the formula of Table VI.
    TABLE VI
    INGREDIENT WEIGHT %
    Polysilicone-11 22.5
    Cyclomethicone 54
    Petrolatum 11
    DMAE Malonate (50% in water) 7
    Dimethicone Copolyol 0.5
  • EXAMPLE 5
  • [0065]
    A relatively anhydrous composition according to the present invention is reported in Table VII.
    TABLE VII
    INGREDIENT WEIGHT %
    Cyclomethicone 80.65
    Dimethicone 9.60
    Squalane 6.00
    Isostearic Acid 1.90
    Borage Seed Oil 0.90
    DMAE Malonate (50% in water) 0.50
    Retinyl Palmitate 0.25
    Ceramide 6 0.10
    Tocopherol 0.10
  • EXAMPLE 6
  • [0066]
    An aerosol packaged foaming cleanser suitable for the present invention is outlined in Table VIII.
    TABLE VIII
    INGREDIENT WEIGHT %
    Sunflower Seed Oil 20.00
    Maleated Soybean Oil 5.00
    Silicone Urethane 1.00
    Polyglycero-4 Oleate 1.00
    Sodium C14-16 Olefin Sulfonate 15.00
    Sodium Lauryl Ether Sulphate (25% active) 15.00
    Cocoamidopropylbetaine 15.00
    DC 1784 ® (Silicone Emulsion 50%) 5.00
    Polyquaternium-11 1.00
    DMAE Malonate 1.00
    Water Balance
  • [0067]
    An aerosol was prepared using 92% by weight of the concentrate in Table VIII and 8% propellant, the latter being a combination of dimethylether, isobutane and propane.
  • EXAMPLE 7
  • [0068]
    An adhesive cosmetic patch may also be formulated according to the present invention. An adhesive hydrogel is prepared by mixing 30 grams of 2-acrylamido-2-methylpropane sulphonic acid monomer in 20 grams distilled water and 5 grams of a 1% aqueous solution of methylene-bis-acrylamide. The solution is then activated with 0.4% magnesium persulphate catalyst. Shortly after mixing the catalyst with the hydrogel solution, 0.1 grams DMAE malonate in 5 ml water is added. The resultant solution is coated onto a 50/50 blend of polypropylene and hydrophilic polyester and allowed to solidify. The resulting deposited hydrogel is warmed for 24 hours at 40° C. in a hot air oven. Final water content of the hydrogel is 50%. A polystyrene backing layer is laid over the adhesive hydrogel.
  • EXAMPLE 8
  • [0069]
    A disposable, single use personal towelette product is described according to the present invention. A 70/30 polyester/rayon non-woven towelette is prepared with a weight of 1.8 grams and dimensions of 15 cm by 20 cm. Onto this towelette is impregnated a composition as outlined in Table IX below.
    TABLE IX
    INGREDIENT WEIGHT %
    DMAE Malonate 7.50
    Glycerin 2.00
    Hexylene Glycol 2.00
    Disodium Capryl Amphodiacetate 1.00
    Gluconolactone 0.90
    Silicone Microemulsion 0.85
    Witch Hazel 0.50
    PEG-40 Hydrogenated Castor Oil 0.50
    Fragrance 0.20
    Vitamin E Acetate 0.001
    Water Balance
  • [0070]
    The foregoing description and examples illustrate selected embodiments of the present invention. In light thereof variations and modifications will be suggested to one skilled in the art, all of which are within the spirit and purview of this invention.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US4105782 *7 Sep 19768 Ago 1978Yu Ruey JTreatment of acne and dandruff
US4105783 *7 Sep 19768 Ago 1978Yu Ruey JTherapeutic treatment of dry skin
US4197316 *17 Ene 19788 Abr 1980Scott Eugene J VanTreatment of dry skin
US4234599 *4 Oct 197818 Nov 1980Scott Eugene J VanTreatment of skin keratoses with α-hydroxy acids and related compounds
US4424234 *29 Dic 19803 Ene 1984Lever Brothers CompanySkin treatment compositions
US4675180 *18 Feb 198623 Jun 1987Ciba-Geigy CorporationProcess for preparing quaternary ammonium salts
US4885282 *8 Mar 19885 Dic 1989Thornfeldt Carl RTreatment of hyperhidrosis, ichthyosis and wrinkling
US5091171 *15 Ago 198925 Feb 1992Yu Ruey JAmphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
US5326790 *16 Abr 19925 Jul 1994Dermatologic Research CorporationAdministration of skin medications by use of dicarboxylic acids and derivatives
US5378455 *27 Dic 19933 Ene 1995Chesebrough-Ponds Usa Co., Division Of Conopco, Inc.Cosmetic composition for inhibiting hair growth
US5554647 *27 Abr 199510 Sep 1996Perricone; Nicholas V.Method and compositions for treatment and/or prevention of skin damage and aging
US5578641 *20 Abr 199426 Nov 1996Elizabeth Arden Co., Division Of Conopco, Inc.Cosmetic composition
US5641495 *17 Oct 199524 Jun 1997Kao CorporationSkin cosmetic containing ceramides of pseudoceramides and dicarboxylic acids and dicarboxylic acid salts
US5643586 *7 Sep 19951 Jul 1997Perricone; Nicholas V.Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
US5650158 *2 Nov 199322 Jul 1997Henkel Kommanditgesellschaft Auf AktienSkin-conditioning succinic acid derivatives
US5939078 *18 Nov 199617 Ago 1999Kao CorporationWrinkle-care product
US6007649 *20 Ene 199728 Dic 1999Bayer AktiengesellschaftMethod of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalysts
US6120789 *30 Mar 199919 Sep 2000Atrix Laboratories, Inc.Non-polymeric sustained release delivery system
US6217887 *1 Jun 199917 Abr 2001The Procter & Gamble CompanyLeave-on antimicrobial compositions which provide improved immediate germ reduction
US6258368 *4 Jun 199710 Jul 2001The Procter & Gamble CompanyAntimicrobial wipes
US6265364 *28 Dic 199924 Jul 2001Colgate-Palmolive CompanySolid cleansing composition comprising a choline salt
US6306848 *8 Oct 199723 Oct 2001Kao CorporationMethod of modifying wrinkles using guanidine derivatives
US6348200 *15 Oct 199619 Feb 2002Kao CorporationCosmetic composition
US6521237 *3 Jun 199918 Feb 2003Johnson & Johnson Consumer Companies, Inc.Skin care composition
US6544531 *9 Nov 19998 Abr 2003Johnson & Johnson Products, Inc.Skin care composition
US6607735 *21 Dic 200019 Ago 2003Johnson & Johnson Consumer Companies, Inc.Method for reducing the appearance of dark circles under the eyes
US20020022596 *23 Feb 200121 Feb 2002Al-Obeidi Fahad A.Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them
US20030017177 *6 Jul 200123 Ene 2003Perricone Nicholas V.Reduction of skin pore size using alkanolamines
US20030021855 *27 Feb 200230 Ene 2003Perricone Nicholas V.Treatment of acne using alkanolamine compositions
US20030095991 *21 Dic 200022 May 2003Curtis ColeTreatment for skin
US20040185015 *23 Jun 200323 Sep 2004Unilever Home & Personal Care Usa, Division Of Conopco, Inc.Sunscreen cosmetic compositions storage stabilized with malonate salts
US20040185073 *23 Jun 200323 Sep 2004Unilever Home & Personal Care Usa, Division Of Conopco, Inc.Cosmetic compositions containing salts of malonic acid
US20040202689 *29 Ene 200414 Oct 2004Unilever Home & Personal Care Usa, Division Of Conopco, Inc.Terpenoid fragrance components stabilized with malonic acid salts
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US768765029 Dic 200630 Mar 2010Jr Chem, LlcChemical compositions and methods of making them
US786752229 Dic 200611 Ene 2011Jr Chem, LlcMethod of wound/burn healing using copper-zinc compositions
US789780029 Ene 20071 Mar 2011Jr Chem, LlcChemical compositions and methods of making them
US792761414 Jun 200619 Abr 2011Jr Chem, LlcAnti-aging treatment using copper and zinc compositions
US814856319 Feb 20103 Abr 2012Jr Chem, LlcChemical compositions and methods of making them
US827379110 Dic 200825 Sep 2012Jr Chem, LlcCompositions, kits and regimens for the treatment of skin, especially décolletage
US850573023 Ago 201213 Ago 2013Jr Chem, LlcCompositions, kits and regimens for the treatment of skin, especially décolletage
US895205716 Jun 201110 Feb 2015Jr Chem, LlcCompositions for anorectal use and methods for treating anorectal disorders
US94273978 Feb 201230 Ago 2016Obagi Medical Products, Inc.Rosacea treatments and kits for performing them
US20040202689 *29 Ene 200414 Oct 2004Unilever Home & Personal Care Usa, Division Of Conopco, Inc.Terpenoid fragrance components stabilized with malonic acid salts
Clasificaciones
Clasificación de EE.UU.424/401, 514/554
Clasificación internacionalA61Q1/00, A61K8/35, A61K8/00, A61K8/30, A61K8/44, A61Q1/14, A61K8/84, A61K8/36, A61Q19/00, A61Q1/02, A61K8/02, A61K8/04, A61K8/362, A61Q19/08, A61K8/41, A61Q19/02, A61Q19/10, A61Q1/12
Clasificación cooperativaA61Q19/08, A61K8/362, A61Q1/02, A61K8/84, A61K8/41, A61Q19/10, A61K8/35, A61Q19/00, A61K8/0208, A61K8/44, A61Q19/02, A61K8/416, A61Q1/12, A61K8/046
Clasificación europeaA61K8/35, A61K8/84, A61K8/44, A61Q1/12, A61Q1/02, A61K8/41, A61K8/02C, A61K8/362, A61K8/04F, A61Q19/02, A61Q19/10, A61K8/41L, A61Q19/08, A61Q19/00
Eventos legales
FechaCódigoEventoDescripción
9 Abr 2003ASAssignment
Owner name: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FARYNIARZ, JOSEPH RAYMOND;JOHNSON, ANTHONY WILLIAM;CHENEY, MICHAEL CHARLES;AND OTHERS;REEL/FRAME:013936/0606;SIGNING DATES FROM 20021008 TO 20030113